Actively responding to the national centralized procurement policy, Beijing Huakang Tianyi Biotechnology Co., Ltd. officially joined the national joint procurement camp. On September 1, 2025, the National Organization for Joint Procurement of High-Value Medical Consumables officially announced that Beijing Huakang Tianyi Biotechnology Co., Ltd. successfully passed the review and became an additional product enterprise for the continued procurement upon the expiration of the artificial joint cent
Approved by NMPA, 3D printed acetabulum product officially approved for market launch On September 25, 2025, the acetabulum component of the 3D printed hip joint prosthesis independently developed by Beijing Huakang Tianyi Biotechnology Co., Ltd. officially received approval from the National Medical Products Administration (NMPA) for market launch. The registration certificate number is GXZZ 20253131932, valid until September 24, 2030. The product consists of an acetabulum shell and an acetabul
The knee joint is one of the most complex and weight-bearing joints in the human body. Statistics show that the prevalence of osteoarthritis among people over 60 years old in China exceeds 55%, with the knee joint being the most commonly affected part. With the accelerated aging of the population and the younger onset of problems such as obesity, sedentary lifestyle, and sports injuries, degenerative knee joint disease is no longer a simple "disease of the elderly", but a public health
As a high-tech medical device enterprise integrating scientific research, production, and sales, Beijing Huakang Tianyi Biotechnology Co., Ltd. was established in 2010 and is located in Mafang Industrial Park, Pinggu District, Beijing. The company boasts a factory area of over 35,000 square meters and advanced modern production and testing equipment. It relies on a team of expert consultants from well-known domestic medical institutions such as Peking Union Medical College Hospital, People'
According to the public information released by the Beijing Municipal Drug Administration, Beijing Huakang Tianyi Biotechnology Co., Ltd. has recently completed the renewal process for its medical device production license. The new license number is "Jingyao Jianxiang Shengchan Xu 20110038", valid from November 6, 2025, to November 5, 2030. The company's production scope covers Class III orthopedic implants, including core product lines such as spinal implants and joint replacemen
Recently, according to the notice issued by the National Joint Procurement Office for High-Value Medical Consumables, Beijing Huakang Tianyi Biotechnology Co., Ltd. (hereinafter referred to as "Huakang Tianyi") successfully applied for adding products and obtained the qualification for selection in the continued procurement after the expiration of the centralized volume procurement agreement for artificial joints. The company applied to accept the selected price for the same product sy
This product consists of a metal liner and a polyethylene liner. The metal liner is made of cast cobalt-chromium-molybdenum alloy material that meets the requirements of YY 0117.3 standard; the polyethylene liner is made of high-dose radiation cross-linked ultra-high molecular weight polyethylene material that meets the requirements of YV/T0811 standard. The metal liner is sterilized by irradiation, while the polyethylene liner is sterilized by ethylene oxide, with a sterilization validity perio
Beijing Huakang Tianyi Biotechnology Co., Ltd. is a "high-tech medical device manufacturing enterprise" integrating scientific research, production, sales, trade services, and import and export. Established in 2010, the company is located in Mafang Industrial Park, Pinggu District, Beijing. Huakang Tianyi boasts advanced modern production equipment such as imported machining centers, turning complexes, CNC lathes, and CNC milling machines, as well as precision testing equipment includi
